Parnax Lab Consolidated March 2023 Net Sales at Rs 40.91 crore, down 14.62% Y-o-Y

Parnax Lab Consolidated December 2020 Net Sales At Rs 24.83 Crore, Down 2.48% Y-o-Y

Price return has been average, nothing exciting

Seems to be overvalued vs the market average

Lagging behind the market in financials growth

Showing good signs of profitability & efficiency

The stock is underpriced and is not in the overbought zone

Current price is less than the intrinsic value

Good time to consider, stock is not in the overbought zone

Parnax Lab is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations